TOSHIBA’S ENCORE VeloCT CONSOLE RECEIVES FDA CLEARANCE

TUSTIN, Calif., June 12, 2012 – To enable hospitals to keep pace with the latest technological advances and offer better patient care and improved workflow while containing costs, Toshiba America Medical Systems, Inc. announces the availability of VeloCT. This console upgrade includes new enhancements for patient safety, dose management and workflow for existing Aquilion 32, Aquilion 64 and Aquilion CX CT systems manufactured between 2006 and 2012.

The VeloCT console includes multiple dose reduction technologies and dose management tools, including:

•          Adaptive Iterative Dose Reduction 3D (AIDR 3D) – This third-generation iterative dose reconstruction software incorporates significant system enhancements by helping to dramatically reduce radiation dose compared to conventional scanning. It is a sophisticated algorithm designed to work in both the raw data and image data space, reducing noise to maintain image quality.
•          NEMA XR 25 Dose Check Software – Enhances user awareness of the radiation dose being administered to patients. This software includes Dose Alert and Dose Notification, addressing the two main components of MITA’s CT Dose Check Initiative.
•          Tracking and Digital Imaging and Communications in Medicine (DICOM), IHE Structured Dose Report – For better dose management and more accurate reporting.
• In addition, the VeloCT console includes advanced hardware that enables accelerated workflow, improving clinical and operational capabilities.

“VeloCT is an example of Toshiba’s commitment to providing customers with advanced dose management tools and workflow solutions to make CT exams even safer,” said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “VeloCT helps customers plan for the future by upgrading today’s existing technology to meet the healthcare needs of tomorrow.”